Skip to content

Human Pharmacokinetic Study of Arginine Acetate Granules

Human Pharmacokinetic Study of Arginine Acetate Granules

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-11001773
Enrollment
Unknown
Registered
2011-12-08
Start date
2005-01-05
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy people

Interventions

Three groups:administration arginine acetategranules

Sponsors

Daping Hospital, Third Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Body mass index(BMI) of 19 to 24 kg/m2 (inclusive); 2. No smoking, drinking or drug addiction before or during the study; 3. No history of cardiovascular, renal, gastrointestinal, hepatic, nervous, psychological disease or metabolic disorders.

Exclusion criteria

Exclusion criteria: 1. Subjects who took any over-the-counter or prescription drugs within two weeks or any arginine drug, food, health-care product, medicated diet within one week; 2. Subjects allergic to arginine; 3. Subjects who participated any investigational drug study within 1 months prior to this study; 4. Menstrual, pregnant or lactating women and women at childbearing age take oral contraceptive; 5. In the opinion of the investigator, subjects who are not suitable to participate in the study for whatever reasons must be excluded.

Design outcomes

Primary

MeasureTime frame
concentrate of arginine acetate in plasma;

Countries

China

Contacts

Public ContactXi Peng

Institute of Burn Research, Southwest Hospital, Third Military Medical University

pxlrmm@163.com+86 023 68754149-8056

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026